Search Results for "alzheimer's treatment"

Many questions linger about this possible Alzheimer’s treatment. So why the avalanche of news coverage?
News organizations rightly reported the numerous asterisks attached to a small mid-stage study of a potential Alzheimer’s treatment highlighted at this week’s Alzheimer’s Association International Conference. As some stories reported, the study was a Phase 2 trial that hasn’t been peer reviewed or published in a journal, in which the drug didn’t meet its primary […]
CBS News story on Alzheimer’s treatment follows familiar formula
The story follows a tired formula of teasing readers with hopeful statements about a potential cure, only to conclude with the caveat that more study is needed to determine whether the idea will actually work.


Can memory loss in Alzheimer's patients be reversed?
Spinning of negative result gives false hope on Alzheimer’s treatment
Subgroup analysis is an important approach to experimental trials that journalists – and the general public need to understand. This news release didn’t even raise the issue.


Prostate Cancer Drug Slows Memory Loss in Women with Alzheimer's Disease
Israeli medical device offers new Alzheimer’s treatment
6 people in the active arm of the study. Unpublished data. Everything comes from the company. Even investors reading a business story deserve better than this.


Israeli medical device offers new Alzheimer’s treatment
Nasal spray shows promise as treatment for Alzheimer’s disease
Longer but not better than a competing Washington Post column about the same study. An independent voice could have helped frame these results with the appropriate context.

Nasal spray shows promise as treatment for Alzheimer’s disease
New questions about treatments for spinal fusion, Alzheimer’s
The New York Times reports, “Medtronic Bone-Growth Product Scrutinized.” Excerpt: “One of Medtronic’s most profitable divisions — selling bone growth products used in spinal fusion procedures — faces growing pressure amid a widening criminal investigation into the company’s marketing of one product and a rejection by federal regulators of another one. Recently, the Food and […]

What you need to know about the Alzheimer’s test news
For years, substances called tau protein or beta-amyloid have been theorized to be signs or causes of Alzheimer’s disease. There have been many reports of tests and treatments based on theories that tau and/or amyloid are at least signs, if not causes, of Alzheimer’s. Scientific uncertainty remains about the precise role of tau and amyloid […]
Guardian jumps to conclusions about an Alzheimer’s study that hasn’t even begun
The story’s headline states: “Virtual reality to help detect early risk of Alzheimer’s.” That is misleading. The researchers haven’t even recruited study participants yet, much less conducted the study or analyzed the results.


Virtual reality to help detect early risk of Alzheimer’s
Johns Hopkins prematurely heralds a ‘promising diagnostic tool’ for Alzheimer’s
This news release did a good job of explaining how the study was done but didn’t provide data on benefits, costs, or harms.


Johns Hopkins team identifies promising diagnostic tool for Alzheimer's disease
USA Today provides rosy speculation about an Alzheimer’s vaccine not yet tested in humans
The story played up wishful conjecture about slashing dementia cases in half.


Researcher: Alzheimer's vaccine could cut dementia in half, human trials may be next

Podcast: The problematic promise of a ‘cure’ for Alzheimer’s disease
The Alzheimer’s Association has fundraising commercials promising breakthroughs and cures for a disease in which the cause is unknown and a treatment hasn’t been found.
Is this irresponsible? Unethical? Potentially harmful?

Podcast: The problematic promise of a ‘cure’ for Alzheimer’s disease
The Alzheimer’s Association has fundraising commercials promising breakthroughs and cures for a disease in which the cause is unknown and a treatment hasn’t been found. Is this irresponsible? Unethical? Potentially harmful?

How the ‘optimism’ narrative in Alzheimer’s helps the drug industry and harms patients
When I think about what will be lost when HealthNewsReview.org closes its doors at the end of 2018, our emphasis on independent expert assessment of health care claims looms as one of the biggest deficits. We’ve pointed out time and again how health care news can be tainted by the influence of industry and hidden […]
HealthDay provides needed details on side effects of THC-based drug studied for Alzheimer’s agitation
However, the story didn’t provide any supporting numbers for the touted benefits.


Could Pot-Linked Drug Help Ease Agitation in Alzheimer's?
No, an asthma drug tested in mice does not bring ‘new hope’ for Alzheimer’s patients, at least not yet
Use of use of words like “breakthrough” and a phrase suggesting the drug offers “new hope” for patients detract from the cautious aspects of this release.

